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measurements were then acquired for 3 clinical prostate 
patients with Compass and film (one of which had failed 
Compass QC, likely due to narrow segments) in a solid water 
phantom and compared. 
 
Results: Profile analysis of the characteristic fields showed 
that for narrow but long fields on axis, the agreement 
between Compass and film was within 3%, slightly inferior to 
the TPS and film comparison at 2%. The worst case was 5% for 
a 1 x 10 cm off-axis field and 4% for irregular fields. The 
clinical films demonstrated that Compass accurately 
modelled dose distribution with 11/12 films achieving at least 
95% gamma passing at 3%/3mm with an average of 97.8 ± 2.1 
% (sd). The failed film achieved 93.6% passing. This was from 
the failed clinical plan – this is more likely due to the blurring 
induced by narrow segments than inaccurate delivery. Figure 
1 shows (a) an isodose for a passing film and (b) a profile 
taken across the film. All films passed when compared 
against the TPS (average gamma 98.3 ± 1.3 %).  
 
 
 
Figure 1. Representative film showing (a) an isodose and (b) a 
profile (dashed line on (a)) showing the Compass (thick) and 
film (thin) where 100% = 3.48 Gy. 
 
Conclusion: By comparison with film measurements, it has 
been shown that Compass is able to reproduce the dose 
distribution of clinical VMAT prostate plans, and is 
sufficiently accurate to detect any clinically relevant errors. 
However, users should be aware that the resolution of the 
Compass reconstruction algorithm is limited when narrow 
segments are predominant.  
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Purpose or Objective: New hybrid systems for patient 
specific pre-treatment QA are suited for 3D gamma (GA) and 
DVH reconstructed analysis (DA). For 2D evaluations, a 
3%/3mm agreement for 90-95% points is considered to be the 
state of art. Recent studies highlighted poor correlation 
between gamma passing rates and DVH clinical goals 
variations on PTV and OARs, so it could improve the situation 
to consider available DVH analysis tools. The aim of this work 
is to test the robustness and sensitivity of VMAT prostate 
patient specific DVH based acceptance criteria (AC) for QA 
using the COMPASS (Iba-Dosimetry) system in combination 
with the RayStation (Ray Search Laboratories) TPS. 
 
Material and Methods: For thirty prostate dual-arc VMAT 
plans, the most relevant DVH indices (DI) were considered for 
the PTV: D98, D95, D50, D1 and Dmean . Clinical doses were 
computed with both, COMPASS and RayStation, which share 
the same calculation algorithm. Plans were delivered with a 
VARIAN Trilogy equipped with a Millenium 120 MLC and 
measured with COMPASS. RayStation vs COMPASS 
reconstructed doses were analyzed in terms of DI differences. 
The AC rely on calculating mean values (m) and standard 
deviations (std) of DI differences and assigning for each DI 
difference a confidence interval equal to 1.5•std. To assess 
the AC robustness in terms of system sensitivity the TG119 
prostate case was optimized using a VMAT single arc 
technique. Three different types of errors were introduced 
individually in the RT-plan to mimic linac delivery 
inaccuracies: a) MU number modification (MU-error) from -3% 
to +4%, b) gantry angle shift (g-error) from 0° to 3° and c) 
widening of both leaf banks (w-error) from 0 to 2 mm. 
Modified plans were delivered and beforehand defined DI 
were calculated. 
 
Results: For RayStation vs COMPASS computed doses analysis 
DI differences < 0.4% have been found. In the TG119 plan PTV 
DI differences showed a linear trend respectively with MU-
errors (see figure) and g-errors. The proposed DVH based 
criteria detected MU-errors below -1.8% or above 1.3% and w-
errors > 1.5mm. The criteria led to the detecting of g-
errors>3°. 
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Conclusion: The defined criteria show high predictive 
capability and robustness to detect MU and w-errors on the 
PTV. On the other hand g-errors are not easy to detect 
mainly because of the central position of the prostate. 
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Purpose or Objective: Due to the excellent spatial 
resolution, Gafchromic® EBT film (Ashland Inc., Wayne, NJ) 
are potentially attractive as a 2D dosimeter for dose 
verification in proton therapy. Multichannel dosimetry (MCD) 
was recently proposed for film calibration, showing improved 
accuracy if compared to single channel dosimetry (SCD), 
since it allows for the separation of the dose-dependent part 
of the film image from non dose-dependent contributions. 
The aim of this study was to test MCD vs SCD for patient plans 
QA in proton therapy. 
 
Material and Methods: We performed irradiations with 
different levels of complexity in both homogeneous and 
anthropomorphic (heterogeneous) phantom. Homogenenous 
phantom: measurements with EBT3 film and MatriXX (Iba 
Dosimetry, Schwarzenbruck, Germany) were carried-out in 
solid water slabs delivering 1) a homogeneous ‘box-like’ dose 
distribution (range 12cm, modulation 6cm, width 5x6cm², 
measured at 9cm depth) and 2) a clinical field measured at 
6cm depth. Anthropomorphic phantom (Proton Therapy 
Dosimetry Head - CIRS 731-HN): films were placed on sagittal 
planes and phantom was irradiated with 1) a homogeneous 
box-like field, 2) a single clinical field and 3) a three beam 
clinical plan (two lateral no-coplanar and one anterior 
oblique). Each film was scanned together with two reference 
films, one non-irradiated and one exposed to a dose around 
80% of the maximum expected dose. The reference films 
provide data for correcting the dose-response function for 
the conditions applying to the particular scan, thus reducing 
the inter-scan variability; this option can be selected in the 
FilmQA™ Pro software used for the analysis. Films were 
scanned with an Epson Expression 10000XL. Measured data 
were compared with those extracted by the TPS (XiO, 
Elekta). 
 
Results: Table 1 shows the results of the gamma analysis for 
both SCD and MCD. An average reduction of about 16% and 
10% was observed for the 2%/2mm and 3%/3mm gamma 
parameters, respectively, when moving from MCD to SCD. 
The standard deviations reported in the table indicate a 
larger variability among the results for SCD compared to 
MCD, thus suggesting that MCD is also effective in reducing 
inter-film variability. Comparing the fields delivered in 
homogeneous vs anthropomorphic phantom, an average 
deterioration by 3% (MCD) is observed in gamma passing rates 
in presence of heterogeneities. 
 
 
 
In figure 1, a comparison between the two methods in terms 
of gamma maps, isodose distributions and profiles is shown. 
 
 
 
Conclusion: In general, the MC optimization strongly 
improves the gamma passing rates when comparing measured 
and calculated dose maps. The proposed method appears to 
be suitable also for patient dose verification in proton 
therapy. 
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Purpose or Objective: Recent technological developments in 
robotic radiotherapy systems have enabled delivery of a large 
number of non-isocentric, non-coplanar beams using the 
InCise™ multi leaf collimator (MLC) system. However, the 
effect of gravity may result in leaf positional errors. We 
investigate the leaf position accuracy of Cyberknife M6 and 
evaluate the effects of leaf position accuracy on the dose 
distribution. 
 
Material and Methods: The leaf position accuracy of 
Cyberknife M6 was tested at the home position and at eleven 
positions that may affect the MLC position accuracy through 
the gravity effect. The position accuracy was analyzed by the 
Bayouth test with an EBT2 film. Further, the dose distribution 
for a prostate cancer patient treatment plan when using the 
MLC was evaluated. Film dosimetry is performed for 
evaluating the dose distribution. Parameters from the patient 
